MRE11 and endometrial endometrioid adenocarcinoma: Consistently, the mutation of MRE11 (G285C) identified in uterine endometrioid carcinoma exhibited a similar cellular phenotype as the UFMylation-defective mutant MRE11 (K282R) [59].